Sugar-Nanocapsules Imprinted with Microbial Molecular Patterns for mRNA Vaccination

Area of Science:

• Immunology
• Nanotechnology
• Vaccine Development

Background:

• Innate immune cells detect pathogen-associated molecular patterns (PAMPs).
• Microbial cell wall polysaccharides are potent activators of dendritic cells (DCs).

Purpose of the Study:

• To introduce a new class of nanocapsules, termed sugar-capsules, made from microbial cell wall polysaccharides.
• To evaluate the potential of these sugar-capsules as vaccine and immunotherapy platforms.

Main Methods:

• Fabrication of sugar-capsules with flexible polysaccharide shells and hollow cores.
• Administration of mannan-based sugar-capsules (Mann-capsules) loaded with mRNA to mice.
• Assessment of DC activation, mRNA translation, antigen presentation, and T-cell responses.

Main Results:

• Sugar-capsules efficiently drain to lymph nodes and activate DCs.
• Mann-capsules loaded with mRNA significantly enhanced DC activation, mRNA translation, and antigen presentation.
• Mann-capsules induced robust antigen-specific CD4+ and CD8α+ T-cell responses with *in vivo* antitumor efficacy.

Conclusions:

• Sugar-capsules represent a novel platform for vaccine and immunotherapy development.
• This strategy leverages pathogen-derived molecular patterns for enhanced immune stimulation.
• The findings support the general applicability of sugar-capsules for generating potent immune responses.